Showing results (771-780 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|August 6, 2021
Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversyMasayuki Kanamori, Hirokazu Takami, Tomonari Suzuki, et al.
Neuro-Oncology Advances|August 6, 2021
Preoperative imaging of glioblastoma patients using hyperpolarized 13C pyruvate: Potential role in clinical decision makingJun Chen, Toral R Patel, Marco C Pinho, et al.
Neuro-Oncology Advances|May 12, 2021
MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international studyLydia T Tam, Kristen W Yeom, Jason N Wright, et al.
Neuro-Oncology Advances|August 1, 2022
Deep learning super-resolution magnetic resonance spectroscopic imaging of brain metabolism and mutant isocitrate dehydrogenase gliomaXianqi Li, Bernhard Strasser, Ulf Neuberger, et al.
Neuro-Oncology Advances|August 22, 2022
The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic reviewKyra X Swildens, Peter A E Sillevis Smitt, Martin J van den Bent, et al.
Neuro-Oncology Advances|August 22, 2022
Prognostic risk stratification of gliomas using deep learning in digital pathology imagesPranathi Chunduru, Joanna J Phillips, Annette M Molinaro
Neuro-Oncology Advances|May 7, 2021
Multicellular "hotspots" harbor high-grade potential in lower-grade gliomasAlastair J Kirby, José P Lavrador, Istvan Bodi, et al.
Neuro-Oncology Advances|August 2, 2021
Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessmentKarine A Al Feghali, James W Randall, Diane D Liu, et al.
Neuro-Oncology Advances|August 2, 2021
The spectrum of mitochondrial DNA (mtDNA) mutations in pediatric CNS tumorsKristiyana Kaneva, Katrina O'Halloran, Petr Triska, et al.
Neuro-Oncology Advances|August 11, 2021
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experienceNazanin K Majd, Maximilan Mastall, Heather Lin, et al.
Pageof 134